| Literature DB >> 34476512 |
Manon L Tolhuisen1,2, Marielle Ernst3, Anne M M Boers4, Scott Brown5, Ludo F M Beenen6, Francis Guillemin7, Yvo B W E M Roos8, Jeffrey L Saver9, Robert van Oostenbrugge10,11, Andrew M Demchuck12, Wim van Zwam13, Tudor G Jovin14, Olvert A Berkhemer6,15,16, Keith W Muir17, Serge Bracard7,18, Bruce C V Campbell19,20, Aad van der Lugt17, Phill White21,22, Michael D Hill12,23,24,25, Diederik W J Dippel15, Peter J Mitchell20, Mayank Goyal12, Matthan W A Caan26, Henk A Marquering26,6, Charles B L M Majoie6.
Abstract
PURPOSE: Follow-up infarct volume (FIV) is moderately associated with functional outcome. We hypothesized that accounting for infarct location would strengthen the association of FIV with functional outcome.Entities:
Keywords: Acute ischemic stroke; Diffusion weighted imaging; Follow-up infarct location; Functional outcome
Mesh:
Year: 2021 PMID: 34476512 PMCID: PMC8850210 DOI: 10.1007/s00234-021-02784-x
Source DB: PubMed Journal: Neuroradiology ISSN: 0028-3940 Impact factor: 2.804
Fig. 1The division of brain regions according to high, moderate and low mRS relevance
Baseline and follow-up characteristics for our subpopulation and those of the HERMES dataset
| Characteristic | Volume analysis subgroup ( | HERMES ( |
|---|---|---|
| Age (years) | 66 ± 14 (251) [69] (59, 76) | 66 ± 14 (1761) [68] (57, 76) |
| Male gender | 49% (124/252) | 53% (929/1762) |
| NIHSS at baseline | 17 ± 4.9 (251) [17] (13, 21) | 17 ± 5.1 (1751) [17] (13, 21) |
| Diabetes mellitus | 16% (40/251) | 16% (287/1756) |
| Atrial fibrillation | 44% (77/177) | 33% (447/1351) |
| Prior stroke | 11% (27/252) | 11% (188/1751) |
| Pre-stroke mRS | ||
| 0 | 81.4% (144/177) | 83% (1057/1280) |
| 1 | 16% (28/177) | 13% (162/1280) |
| 2 + | 2.8% (5/177) | 4.8% (61/1280) |
| Occlusion location | ||
| ICA-T | 22% (55/246) | 20.2% (350/1731) |
| M1 | 72% (176/246) | 73.8% (1277/1731) |
| M2 | 6.1% (15/246) | 6.0% (104/1731) |
| EVT allocation | 52% (131/252) | 49% (871/1764) |
| tPA delivered | 93% (233/252) | 89% (1572/1764) |
| Treatment | ||
| EVT + tPA | 46% (117/252) | 43% (763/1764) |
| EVT only | 5.6% (14/252) | 6.1% (108/1764) |
| tPA only | 46% (116/252) | 46% (809/1764) |
| Best medical management | 2.0% (5/252) | 4.8% (84/1764) |
| Onset to randomization (min) | 195 ± 97.6 (252) [180] (130.0,233.0) | 202 ± 89 (1756) [183] (140.0,245.0) |
| NIHSS at baseline | ||
| 0–4 | 0.4% (1/251) | 0.4% (7/1751) |
| 5–15 | 42% (105/251) | 37% (647/1751) |
| 16–20 | 32% (81/251) | 37% (655/1751) |
| 21–42 | 26% (64/251) | 25% (442/1751) |
| TICI 2b/3 (EVT-treated subjects only) | 84% (97/115) | 75% (550/729) |
| Favorable outcome at 90 days | 53% (133/249) | 47% (462/978) |
Fig. 2An example of the infarct segmentations on diffusion weighted MRI in areas with different mRS relevance
Fig. 3Infarct distribution shown for the axial (a), coronal (b) and sagittal (c) slice with the largest infarct probability present
Fig. 4Box plots showing the infarct volume distribution per mRS category for the low (a), moderate (b) and high (c) mRS-relevant infarct regions and the total infarct volume (d)
Fig. 5Lesion volume distribution classified as low, moderate and high mRS relevant. Total lesion volume increases along the x-axis. Each bar represents a single subject
Associations between the total follow-up infarct lesion volume and the follow-up infarct lesion volume divided in high, moderate and low mRS-relevant regions and favorable mRS at 90 days
| OR | AIC | c-stat | aOR | ||
|---|---|---|---|---|---|
| Logistic regression (favorable outcome, mRS ≤ 2) | |||||
| Univariable | |||||
| Model 1 | Total FIV | 0.83 (0.77, 0.89) | 300 | 0.75 | 0.78 (0.70, 0.86) |
| Model 2 | High mRS-relevant FIV | 0.62 (0.53, 0.74) | 295 | 0.76 | 0.53 (0.42, 0.67) |
| Model 3 | Moderate mRS-relevant FIV | 0.72 (0.62, 0.83) | 322 | 0.74 | 0.66 (0.54, 0.81) |
| Model 4 | Low mRS-relevant FIV | 0.50 (0.38, 0.66) | 309 | 0.70 | 0.45 (0.31, 0.65) |
| Multivariable | |||||
| Model 5 | High mRS-relevant FIV | 0.67 (0.53, 0.84) | 298 | 0.76 | 0.56 (0.41, 0.76) |
| Moderate mRS-relevant FIV | 1.00 (0.80, 1.25) | 0.87 (0.66, 1.16) | |||
| Low mRS-relevant FIV | 0.86 (0.54, 1.35) | 1.12 (0.65, 1.95) | |||
| Ordinal logistic regression (shift towards better outcome) | |||||
| Univariable | |||||
| Model 6 | Total FIV | 0.84 (0.81, 0.88) | 830 | 0.72 | 0.83 (0.79, 0.87) |
| Model 7 | High mRS-relevant FIV | 0.70 (0.64, 0.77) | 837 | 0.72 | 0.67 (0.60, 0.78) |
| Model 8 | Moderate mRS-relevant FIV | 0.72 (0.65, 0.80) | 859 | 0.71 | 0.69 (0.61, 0.78) |
| Model 9 | Low mRS-relevant FIV | 0.52 (0.44, 0.62) | 841 | 0.69 | 0.51 (0.42, 0.62) |
| Multivariable | |||||
| Model 10 | High mRS-relevant FIV | 0.79 (0.69, 0.91) | 832 | 0.72 | 0.76 (0.65, 0.89) |
| Moderate mRS-relevant FIV | 0.89 (0.77, 1.04) | 0.83 (0.67, 1.37) | |||
| Low mRS-relevant FIV | 0.86 (0.62, 1.21) | 0.96 (0.67, 1.37) | |||
†Adjusted for age, sex, diabetes mellitus, atrial fibrillation, previous stroke or pre-stroke mRS > 0, treatment allocation, occlusion site, time from stroke onset to treatment and the collateral score